Dec 7, 2007
Bortezomib before & after high-dose therapy in myeloma: phase III HOVON-65/GMMG-HD4 trial
HOVON-65/GMMG-HD4 trial Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4...
236
Dec 8, 2005
NCT00200681 : Phase 3- IFM 2005-01: Velcade/Dex Vs Vincristine/Adriamycin/Dex (VAD) for MM
IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With...
491
Dec 10, 2004
NCT00083551: UARK 98-026, Total Therapy II - A Phase III Study for Newly Diagnosed Multiple Myeloma
This study has been designed to evaluate whether "anti-angiogenesis" therapy with thalidomide and whether additional chemotherapy after...
271
Dec 4, 2004
PMID 6546971: Effective treatment of advanced multiple myeloma refractory to alkylating agents
N Engl J Med May 24, 1984 Effective treatment of advanced multiple myeloma refractory to alkylating agents. Barlogie B, Smith L,...
263
Dec 23, 2000
IFM trial: Conventional chemo or high-dose therapy and auto bone marrow transplantation - NEJM 1996
IFM - (Intergroupe Francophone du Myélome) Time Frame: October 1990 and May 1993 IFM trial: Conventional chemo or high-dose therapy and...
53
Dec 14, 2000
Total therapy with tandem transplants for newly diagnosed multiple myeloma Blood 1999
Time Frame: August 1990 and August 1995 Total therapy with tandem transplants for newly diagnosed multiple myeloma Blood; 1999 B Barlogie...
48